was removed from pMCE5-2 ADHNF-CamF35H by digestion with FseI/PmeI, and subcloned into the FseI/SwaI sites of pB319 (pB332, pBF3H-Ci:CamF35H).
To create the NtADH-5-UTR-fused CtA35GT construct, first, we amplified two primary PCR products from pBCtBGT1DB24 containing CtA35GT cDNA by primer set 7, and from pBI221 ADH-221 by primer set 8. A DNA fragment in which the NtADH-5UTR was directly coupled to the start codon of CtA35GT was obtained by PCR using two primary amplified DNA fragments as templates and primer set 9. This DNA fragment was cloned into pCR2.1-TA and then digested with XbaI and HindIII, and the resulting DNA fragment was ligated into XbaI/HindIII-digested pBluescriptII SK( + ) to obtain a pBSII-ADH-5-Ct35GT-HindIII plasmid. We cloned the HindIII/XhoI insert fragment of pBSII-ADH-5-Ct35GT-HindIII into the HindIII/XhoI site of pBCtBGT1DB24 (pBSII-ADH-CtA3'5'GT). The NtADH-5UTR:CtA35GT fragment obtained from pBSII-ADH-CtA3'5'GT by NheI/EcoICRI digestion was subcloned into the NheI/EcoICRI sites of pMCE5-2 (pMCE5-2 ADHNF-CtA3'5'GT). The CmF3Hp:NtADH-5'UTR:CtA3'5'GT:AtHSPt cassette was removed from pMCE5-2 ADHNF-CtA3'5'GT with FseI/PmeI, and subcloned into the FseI/SwaI sites of pB332 (pB428, pBF3H-Ci:CamF35H:CtA35GT, fig. S2B ). The sequence of the CmF3H
RNAi cassette has been registered in DDBJ/ENA/GenBank under accession code LC222468.
We constructed the binary vector pB423 for co-expression of CamF35H and CtA35GT as follows. The NtADH-5UTR fused to CtA35GT was amplified from pBSII-ADH-CtA3'5'GT with primer set 10, and ligated into pCR-BluntII-TOPO (Thermo Fisher Scientific). The NtADH-5UTR-CtA35GT DNA fragment from the NheI/EcoICRI digest was cloned into pBI121 HANS-CmF3Hp1k-S (pB249, fig.S2B ). The CmF3Hp:NtADH-5'UTR:CamF3'5'H:AtHSPt cassette from the AscI/PmeI digest of pMCE5-2 ADHNF-CamF35H was subcloned into the AscI/SwaI sites of pB249 (pB423, CtA35GT:CamF35H;
fig. S2, A and B). We registered the sequence of the CtA35GT and CamF35H cassettes in DDBJ/ENA/GenBank under accession code LC222467. Delphinidin-based anthocyanins. The A3 and A8 structures were determined by 1 H-NMR and NOESY spectra. The NOESY spectra of A3 and A8 indicated that glucose was connected at aglycon-3-OH, 3-OH, and/or 5-OH through a glycosyl bond. The structures of A1-A2, A4-A7 and A9-A10 were putatively identified by LC-MS/MS spectra as follows: A1, cyanidin 3-(6-malonyl)glucoside; A2, cyanidin 3-(3,6dimalonyl)glucoside; A3, cyanidin 3-(6-malonyl)glucoside-3-glucoside; A4, cyanidin 3-(3,6-dimalonyl)glucoside-3'-glucoside; A5, delphinidin 3-(6-malonyl)glucoside; A6, delphinidin 3-(3,6-dimalonyl)glucoside; A7, delphinidin 3,3,5-triglucoside The epidermal tissues were obtained by using tweezers. Caffeoylquinates Q1 and Q2 were trace levels in epidermal tissues containing anthocyanins. Q1, 3-caffeoylquinic acid; Q2, 3,5-dicaffeoylquinic acid; C1, luteolin 7-malonylglucoside; C2, tricetin 7malonylglucoside; F1, apigenin 7-malonylglucoside; F2, acacetin 7-malonylglucoside. Fd ADH-3'5'GT-Fd CAAGAAAAATAAATGGAAAACAATAAGCATGTC Ct3'5' 
Compound characterization data.
(preternatin C5); A8, delphinidin 3-(6-malonyl)glucoside-3,5-diglucoside (ternatin C5); A9, delphinidin 3-(3,6-dimalonyl)glucoside-3,5-diglucoside; A10, delphinidin 3-(6-malonyl)glucoside-3'-glucoside. (C) A11, delphinidin 3-(6-malonyl)glucoside- 3,5-di-(6,6-p-coumaroyl)glucoside (ternatin D3).
